Colgate-Palmolive (India) Ltd's Q4 FY26 numbers came in mixed, with revenue of Rs. 1,583.00 Cr (+9.00% YoY) and PAT growth of -0.50% YoY. Here's a quick read of what worked, what to watch, and what management said.
| Results date | May 22, 2026 |
|---|---|
| Quarter | Q4 FY 2025-2026 |
| Revenue (Q4) | Rs. 1,583.00 Cr (+9.00% YoY) |
| PAT (Q4) | Rs. 353.00 Cr (-0.50% YoY) |
| EBITDA margin | 30.91% (-314 bps YoY) |
| EPS (Q4) | Rs. 12.99 (-0.50% YoY) |
| Market cap | Rs. 58,724.38 Cr |
| CMP | Rs. 2,159.10 |
Colgate-Palmolive India delivered a strong Q4 revenue recovery (+9% YoY) after a flat FY26 full year, with premiumization and rural outperformance as key growth drivers. However, EBITDA margin of 30.6% for FY26 missed management's 32-34% guidance target by ~150-250 bps, and operating expenses grew faster than revenue. The company generated exceptional free cash flow of Rs.1,730 crore, supporting near-100% dividend payout, but the margin miss and flat topline for the year temper the positive signals from the quarterly acceleration.
Disclaimer: This is an AI-generated analysis based on public filings. It is not investment advice, not a recommendation to buy/sell/hold any security, and is not prepared by a SEBI-registered Research Analyst or Investment Adviser.
Powered by CompoundingAI — AI research platform for Indian stocks, every claim cited from primary filings
Login Now